[Federal Register: December 28, 2005 (Volume 70, Number 248)]
[Notices]
[Page 76795]
[DOCID:fr28de05-79]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. EL06-29-000]

Entergy Louisiana, Inc.; Notice of Filing

December 21, 2005.
    Take notice that on December 13, 2005, Entergy Louisiana, Inc.
(ELI) submitted a Petition for Declaratory Order in which ELI has
requested a determination that the payment of dividends by Entergy
Louisiana, LLC out of Membership Interest accounts after it completes a
corporate restructuring on or about December 31, 2005 will not violate
section 305(a) of the Federal Power Act.
    Any person desiring to intervene or to protest this filing must
file in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211, 385.214). Protests will be
considered by the Commission in determining the appropriate action to
be taken, but will not serve to make protestants parties to the
proceeding. Any person wishing to become a party must file a notice of
intervention or motion to intervene, as appropriate. Such notices,
motions, or protests must be filed on or before the comment date. On or
before the comment date, it is not necessary to serve motions to
intervene or protests on persons other than the Applicant.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper using the ``eFiling'' link at http://www.ferc.gov.
 Persons unable to file electronically should submit an

original and 14 copies of the protest or intervention to the Federal
Energy Regulatory Commission, 888 First Street, NE., Washington, DC
20426.
    This filing is accessible on-line at http://www.ferc.gov, using the

``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For

TTY, call<PHONE_NUMBER>.
    Comment Date: 5 p.m. Eastern Time on December 29, 2005.

Magalie R. Salas,
Secretary.
[FR Doc. E5-7937 Filed 12-27-05; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register Volume 84, Number 34 (Wednesday, February 20, 2019)]
[Rules and Regulations]
[Pages 4998-5000]
[FR Doc No: 2019-02824]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 872

[Docket No. FDA-2019-N-0142]

Medical Devices; Dental Devices; Classification of the Auto
Titration Device for Oral Appliances

AGENCY: Food and Drug Administration, HHS.

ACTION: Final order.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or we) is classifying
the auto titration device for oral appliances into class II (special
controls). The special controls that apply to the device type are
identified in this order and will be part of the codified language for
the auto titration device for oral appliances' classification. We are
taking this action because we have determined that classifying the
device into class II (special controls) will provide a reasonable
assurance of safety and effectiveness of the device. We believe this
action will also enhance patients' access to beneficial innovative
devices, in part by reducing regulatory burdens.

DATES: This order is effective February 20, 2019. The classification
was applicable on August 23, 2018.

FOR FURTHER INFORMATION CONTACT: Anita Belani, Center for Devices and
Radiological Health, Food and Drug Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. G314, Silver Spring, MD 20993-0002,<PHONE_NUMBER>,
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. Background

    Upon request, FDA has classified the auto titration device for oral
appliances as class II (special controls), which we have determined
will provide a reasonable assurance of safety and effectiveness. In
addition, we believe this action will enhance patients' access to
beneficial innovation, in part by reducing regulatory burdens by
placing the device into a lower device class than the automatic class
III assignment.
    The automatic assignment of class III occurs by operation of law
and without any action by FDA, regardless of the level of risk posed by
the new device. Any device that was not in commercial distribution
before May 28, 1976, is automatically classified as, and remains
within, class III and requires premarket approval unless and until FDA
takes an action to classify or reclassify the device (see 21 U.S.C.
360c(f)(1)). We refer to these devices as ``postamendments devices''
because they were not in commercial distribution prior to the date of
enactment of the Medical Device Amendments of 1976, which amended the
Federal Food, Drug, and Cosmetic Act (FD&C Act).
    FDA may take a variety of actions in appropriate circumstances to
classify or reclassify a device into class I or II. We may issue an
order finding a new device to be substantially equivalent under section
513(i) of the FD&C Act (21 U.S.C. 360c(i)) to a predicate device that
does not require premarket approval. We determine whether a new device
is substantially equivalent to a predicate

by means of the procedures for premarket notification under section
510(k) of the FD&C Act (21 U.S.C. 360(k)) and part 807 (21 CFR part
807).
    FDA may also classify a device through ``De Novo'' classification,
a common name for the process authorized under section 513(f)(2) of the
FD&C Act. Section 207 of the Food and Drug Administration Modernization
Act of 1997 (Pub. L. 105-115) established the first procedure for De
Novo classification. Section 607 of the Food and Drug Administration
Safety and Innovation Act (Pub. L. 112-144) modified the De Novo
application process by adding a second procedure. A device sponsor may
utilize either procedure for De Novo classification.
    Under the first procedure, the person submits a 510(k) for a device
that has not previously been classified. After receiving an order from
FDA classifying the device into class III under section 513(f)(1) of
the FD&C Act, the person then requests a classification under section
513(f)(2).
    Under the second procedure, rather than first submitting a 510(k)
and then a request for classification, if the person determines that
there is no legally marketed device upon which to base a determination
of substantial equivalence, that person requests a classification under
section 513(f)(2) of the FD&C Act.
    Under either procedure for De Novo classification, FDA is required
to classify the device by written order within 120 days. The
classification will be according to the criteria under section
513(a)(1) of the FD&C Act. Although the device was automatically within
class III, the De Novo classification is considered to be the initial
classification of the device.
    We believe this De Novo classification will enhance patients'
access to beneficial innovation, in part by reducing regulatory
burdens. When FDA classifies a device into class I or II via the De
Novo process, the device can serve as a predicate for future devices of
that type, including for 510(k)s (see 21 U.S.C. 360c(f)(2)(B)(i)). As a
result, other device sponsors do not have to submit a De Novo request
or premarket approval application to market a substantially equivalent
device (see 21 U.S.C. 360c(i), defining ``substantial equivalence'').
Instead, sponsors can use the 510(k) process, when necessary, to market
their device.

II. De Novo Classification

    For this device, FDA issued an order on November 23, 2016, finding
the MATRx plus not substantially equivalent to a predicate not subject
to premarket approval application. Thus, the device remained in class
III in accordance with section 513(f)(1) of the FD&C Act when we issued
the order.
    On December 21, 2017, Zephyr Sleep Technologies submitted a request
for De Novo classification of the MATRx plus. FDA reviewed the request
in order to classify the device under the criteria for classification
set forth in section 513(a)(1) of the FD&C Act.
    We classify devices into class II if general controls by themselves
are insufficient to provide reasonable assurance of safety and
effectiveness, but there is sufficient information to establish special
controls that, in combination with the general controls, provide
reasonable assurance of the safety and effectiveness of the device for
its intended use (see 21 U.S.C. 360c(a)(1)(B)). After review of the
information submitted in the request, we determined that the device can
be classified into class II with the establishment of special controls.
FDA has determined that these special controls, in addition to the
general controls, will provide reasonable assurance of the safety and
effectiveness of the device.
    Therefore, on August 23, 2018, FDA issued an order to the requester
classifying the device into class II. FDA is codifying the
classification of the device by adding 21 CFR 872.5571. We have named
the generic type of device auto titration device for oral appliances,
and it is identified as a prescription home use device that determines
a target position to be used for a final oral appliance for the
reduction of snoring and mild to moderate obstructive sleep apnea.
    FDA has identified the following risks to health associated
specifically with this type of device and the measures required to
mitigate these risks in table 1.

 Table 1--Auto Titration Device for Oral Appliances Risks and Mitigation
                                Measures
------------------------------------------------------------------------
            Identified risks                   Mitigation measures
------------------------------------------------------------------------
Adverse tissue reaction................  Biocompatibility evaluation.
Infection..............................  Reprocessing validation and
                                          Labeling.
Intraoral/temporomandibular joint        Clinical performance testing;
 injury, irritation, or pain due to:      Human factors assessment; Non-
                                          clinical performance testing;
                                          Software verification,
                                          validation, and hazard
                                          analysis; Electrical safety
                                          testing; Electromagnetic
                                          compatibility testing; and
                                          Wireless coexistence testing.
     Use error
     Algorithm-directed
     positioning
     Interference with other
     devices
     Device electrical failure
Incorrect titration level due to use     Human factors assessment and
 error.                                   Labeling.
Disruption of sleep....................  Labeling.
Temporary change in bite or dentition..  Labeling.
------------------------------------------------------------------------

    FDA has determined that special controls, in combination with the
general controls, address these risks to health and provide reasonable
assurance of safety and effectiveness. For a device to fall within this
classification, and thus avoid automatic classification in class III,
it would have to comply with the special controls named in this final
order. The necessary special controls appear in the regulation codified
by this order. This device is subject to premarket notification
requirements under section 510(k) of the FD&C Act.
    At the time of classification, auto titration devices for oral
appliances are for prescription use only. Prescription devices are
exempt from the requirement for adequate directions for use for the
layperson under section 502(f)(1) of the FD&C Act (21 U.S.C. 352(f)(1))
and 21 CFR 801.5, as long as the conditions of 21 CFR 801.109 are met
(referring to 21 U.S.C. 352(f)(1)).

III. Analysis of Environmental Impact

    The Agency has determined under 21 CFR 25.34(b) that this action is
of a type that does not individually or cumulatively have a significant
effect on

the human environment. Therefore, neither an environmental assessment
nor an environmental impact statement is required.

IV. Paperwork Reduction Act of 1995

    This final order establishes special controls that refer to
previously approved collections of information found in other FDA
regulations and guidance. These collections of information are subject
to review by the Office of Management and Budget (OMB) under the
Paperwork Reduction Act of 1995 (44 U.S.C. 3501-3520). The collections
of information in the guidance document ``De Novo Classification
Process (Evaluation of Automatic Class III Designation)'' have been
approved under OMB control number 0910-0844; the collections of
information in 21 CFR part 820, regarding quality system regulation,
have been approved under OMB control number 0910-0073; the collections
of information in 21 CFR part 814, subparts A through E, regarding
premarket approval, have been approved under OMB control number 0910-
0231; the collections of information in part 807, subpart E, regarding
premarket notification submissions, have been approved under OMB
control number 0910-0120; and the collections of information in 21 CFR
part 801, regarding labeling, have been approved under OMB control
number 0910-0485.

List of Subjects in 21 CFR Part 872

    Medical devices.

    Therefore, under the Federal Food, Drug, and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs, 21 CFR part
872 is amended as follows:

PART 872--DENTAL DEVICES

0
1. The authority citation for part 872 continues to read as follows:

    Authority: 21 U.S.C. 351, 360, 360c, 360e, 360j, 360l, 371.

0
2. Add Sec.  872.5571 to subpart F to read as follows:

Sec.  872.5571  Auto titration device for oral appliances.

    (a) Identification. An auto-titration device for oral appliances is
a prescription home use device that determines a target position to be
used for a final oral appliance for the reduction of snoring and mild
to moderate obstructive sleep apnea.
    (b) Classification. Class II (special controls). The special
controls for this device are:
    (1) Clinical performance testing must evaluate the following:
    (i) Performance characteristics of the algorithm; and
    (ii) All adverse events.
    (2) Non-clinical performance testing must demonstrate that the
device performs as intended under anticipated conditions for use,
including the following:
    (i) Validation of the closed loop algorithm;
    (ii) Mechanical integrity over the expected use life;
    (iii) Characterization of maximum force, distance, and speed of
device movement; and
    (iv) Movement accuracy of intraoral components.
    (3) Performance testing must demonstrate the wireless
compatibility, electrical safety, and electromagnetic compatibility of
the device in its intended use environment.
    (4) Software verification, validation, and hazard analysis must be
performed.
    (5) The patient-contacting components of the device must be
demonstrated to be biocompatible.
    (6) Performance data must validate the reprocessing instructions
for any reusable components.
    (7) Patient labeling must include:
    (i) Information on device use, including placement of sensors and
mouthpieces;
    (ii) A description of all alarms; and
    (iii) Instructions for reprocessing any reusable components.
    (8) A human factors assessment must evaluate simulated use of the
device in a home use setting.

    Dated: February 14, 2019.
Lowell J. Schiller,
Acting Associate Commissioner for Policy.
[FR Doc. 2019-02824 Filed 2-19-19; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register Volume 85, Number 162 (Thursday, August 20, 2020)]
[Proposed Rules]
[Page 51395]
[FR Doc No: 2020-17158]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 174

[EPA-HQ-OPP-2019-0508; FRL-10002-27]
RIN 2070-AK54

Notification of Submission to the Secretary of Agriculture;
Pesticides; Exemptions of Certain Plant-Incorporated Protectants (PIPs)
Derived From Newer Technologies

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notification of submission to the Secretary of Agriculture.

-----------------------------------------------------------------------

SUMMARY: This document notifies the public as required by the Federal
Insecticide, Fungicide, and Rodenticide Act (FIFRA) that the EPA
Administrator has forwarded to the Secretary of the U.S. Department of
Agriculture (USDA) a draft regulatory document concerning ``Pesticides;
Exemptions of Certain Plant-Incorporated Protectants (PIPs) Derived
from Newer Technologies.'' The draft regulatory document is not
available to the public until after it has been signed and made
available by EPA.

DATES: See Unit I. under SUPPLEMENTARY INFORMATION.

ADDRESSES: The docket for this action, identified by docket
identification (ID) number EPA-HQ-OPP-2019-0508, is available at http://www.regulations.gov or at the Office of Pesticide Programs Regulatory
Docket (OPP Docket) in the Environmental Protection Agency Docket
Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW, Washington, DC 20460-0001. The Public Reading
Room is open from 8:30 a.m. to 4:30 p.m., Monday through Friday,
excluding legal holidays. The telephone number for the Public Reading
Room is<PHONE_NUMBER>, and the telephone number for the OPP Docket is
(703) 305-5805. Please review the visitor instructions and additional
information about the docket available at http://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT: Anne Overstreet, Biopesticides and
Pollution Prevention Division (7511P), Office of Pesticide Programs,
Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington
DC 20460-0001; telephone number:<PHONE_NUMBER>; email address:
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. What action is EPA taking?

    Section 25(a)(2)(A) of FIFRA requires the EPA Administrator to
provide the Secretary of USDA with a copy of any draft proposed rule at
least 60 days before signing it in proposed form for publication in the
Federal Register. The draft proposed rule is not available to the
public until after it has been signed by EPA. If the Secretary of USDA
comments in writing regarding the draft proposed rule within 30 days
after receiving it, the EPA Administrator shall include the comments of
the Secretary of USDA and EPA Administrator's response to those
comments with the proposed rule that publishes in the Federal Register.
If the Secretary of USDA does not comment in writing within 30 days
after receiving the draft proposed rule, the EPA Administrator may sign
the proposed rule for publication in the Federal Register any time
after the 30-day period.

II. Do any Statutory and Executive Order reviews apply to this
notification?

    No. This document is merely a notification of submission to the
Secretary of USDA. As such, none of the regulatory assessment
requirements apply to this document.

List of Subjects in 40 CFR Part 174

    Environmental protection, Administrative practice and procedure,
Agricultural commodities, Pesticides and pests, Plant-incorporated
protectants, Reporting and recordkeeping requirements.

    Dated: July 31, 2020.
Alexandra Dapolito Dunn,
Assistant Administrator, Office of Chemical Safety and Pollution
Prevention.
[FR Doc. 2020-17158 Filed 8-19-20; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 88, Number 80 (Wednesday, April 26, 2023)]
[Notices]
[Pages 25401-25402]
[FR Doc No: 2023-08793]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPPT-2017-0692; FRL-10561-01-OCSPP]

Agency Information Collection Activities; Proposed Renewal and
Request for Comment; Lead Training, Certification, Accreditation and
Authorization Activities

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the Paperwork Reduction Act (PRA), this
document announces the availability of and solicits public comment on
the following Information Collection Request (ICR) that EPA is planning
to submit to the Office of Management and Budget (OMB): ``Lead
Training, Certification, Accreditation and Authorization Activities,''
identified by EPA ICR No. 2507.05 and OMB Control No. 2070-0195. This
ICR represents the renewal of a currently approved ICR that is
currently scheduled to expire on February 29, 2024. Before submitting
the ICR to OMB for review and approval under the PRA, EPA is soliciting
comments on specific aspects of the information collection that is
summarized in this document. The ICR and accompanying material are
available in the docket for public review and comment.

DATES: Comments must be received on or before June 26, 2023.

ADDRESSES: Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPPT-2017-0692, through the Federal eRulemaking
Portal at https://www.regulations.gov. Follow the online instructions
for submitting comments. Do not submit electronically any information
you consider to be Confidential Business Information (CBI) or other
information whose disclosure is restricted by statute. Additional
instructions on commenting or visiting the docket, along with more
information about dockets generally, is available at https://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT: Katherine Sleasman, Mission Support
Division (7101M), Office of Program Support, Office of Chemical Safety
and Pollution Prevention, Environmental Protection Agency, 1200
Pennsylvania Ave. NW, Washington, DC 20460-0001; telephone number:
(202) 566-1204; email address: [email protected].

SUPPLEMENTARY INFORMATION:

I. What information is EPA particularly interested in?

    Pursuant to PRA section 3506(c)(2)(A) (44 U.S.C. 3506(c)(2)(A)),
EPA specifically solicits comments and information to enable it to:
    1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the Agency,
including whether the information will have practical utility.
    2. Evaluate the accuracy of the Agency's estimates of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used.
    3. Enhance the quality, utility, and clarity of the information to
be collected.
    4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses. In particular, EPA is requesting comments from
very small businesses (those that employ less than 25) on examples of
specific additional efforts that EPA could make to reduce the paperwork
burden for very small businesses affected by this collection.

II. What is the information collection activity?

    Title: Lead Training, Certification, Accreditation and
Authorization Activities.
    EPA ICR No.: 2507.05.
    OMB Control No.: 2070-0195.
    ICR status: This ICR is currently approved through February 29,
2024. Under the PRA, an agency may not conduct or sponsor, and a person
is not required to respond to, a collection of information, unless it
displays a currently valid OMB control number. The OMB control numbers
for EPA's regulations in title 40 of the Code of Federal Regulations
(CFR), after appearing in the Federal Register when approved, are
displayed either by publication in the Federal Register or by other
appropriate means, such as on the related collection instrument,
electronic reporting system or form, if applicable. The display of OMB
control numbers for certain EPA regulations is consolidated in 40 CFR
part 9.
    Abstract: This ICR covers the information collection activities
associated with the reporting and recordkeeping requirements for
individuals, firms and state and local government entities conducting
lead-based paint (LBP) activities or renovations of target housing and
child-occupied facilities (COFs); training providers; and states/
territories/tribes/Alaskan native villages that are promulgated in 40
CFR part 745.
    Burden statement: The annual public reporting and recordkeeping
burden for this collection of information is estimated to range between
.2 and 28.5 hours per response. Burden is defined in 5 CFR 1320.3(b).
    The ICR, which is available in the docket along with other related
materials, provides a detailed explanation of the collection activities
and the burden estimate that is only briefly summarized here:
    Respondents/affected entities: Entities potentially affected by
this ICR include persons who are engaged in LBP activities and/or
perform renovations of target housing or COFs for compensation, dust
sampling, or dust testing; or who perform LBP inspections, lead hazard
screens, risk assessments or abatements in target housing or COFs; or
who provide training or operate a training program for individuals who
perform any of these activities; or state, territorial or Native
American agencies that administer LBP activities and/or renovation
programs.
    Respondent's obligation to respond: Mandatory under TSCA and 40 CFR
part 745.
    Frequency of response: Occasional.
    Total estimated number of potential respondents: 441,034.
    Total estimated average number of responses for each respondent:
61.9.
    Total estimated annual burden: 6,290,360 hours.
    Total estimated annual costs: $362,279,573. This includes an
estimated burden cost of $360,166,618 and an estimated cost of
$17,400,556 for capital investment or maintenance and operational
costs.

III. What are the changes in the estimates from the last approval?

    There is an increase of 1,039,040 hours in the total estimated
respondent burden compared with that identified in the ICR currently
approved by OMB. This increase reflects EPA's estimated increased
number of respondents for several of the information collection
categories addressed in the ICR. This

change is an adjustment. Several adjustments to the estimates were
made, including revisions to the estimated number of respondents based
on the number of respondents reporting to EPA for the prior information
collection and revisions based on other market factors. Changes in
burden estimates reflect changes within the housing renovation market,
as measured by EPA's Federal Lead-Based Paint Program (FLPP) database,
which tracks LBP and Renovation, Repair, and Painting (RRP) program
activity over time, as reported to the Agency. The information
submitted under the LBP activities and RRP programs is managed through
the use of the FLPP database. Pursuant to the provisions of the Privacy
Act of 1974, EPA published a System of Record Notice for the database.
The Agency uses the FLPP Database to manage and store information
related to the application process for the accreditation of training
providers and the certification of firms and individuals who perform
abatement and renovation repair and painting activities.
    In addition, OMB has requested that EPA move towards using the 18-
question format for ICR Supporting Statements used by other federal
agencies and departments and that is based on the submission
instructions established by OMB in 1995, replacing the alternate format
developed by EPA and OMB prior to 1995. The Agency does not expect this
change in format to result in substantive changes to the information
collection activities or related estimated burden and costs.

IV. What is the next step in the process for this ICR?

    EPA will consider the comments received and amend the ICR as
appropriate. The final ICR package will then be submitted to OMB for
review and approval pursuant to 5 CFR 1320.12. EPA will issue another
Federal Register document pursuant to 5 CFR 1320.5(a)(1)(iv) to
announce the submission of the ICR to OMB and the opportunity to submit
additional comments to OMB. If you have any questions about this ICR or
the approval process, please contact the person listed under FOR
FURTHER INFORMATION CONTACT.
    Authority: 44 U.S.C. 3501 et seq.

    Dated: April 20, 2023.
Michal Freedhoff,
Assistant Administrator, Office of Chemical Safety and Pollution
Prevention.
[FR Doc. 2023-08793 Filed 4-25-23; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 78, Number 118 (Wednesday, June 19, 2013)]
[Notices]
[Page 36820]
[FR Doc No: 2013-14345]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Pipeline and Hazardous Materials Safety Administration

List of Applications Delayed

AGENCY: Pipeline and Hazardous Materials Safety Administration (PHMSA),
DOT.

ACTION: List of applications delayed more than 180 days.

-----------------------------------------------------------------------

SUMMARY: In accordance with the requirements of 49 U.S.C. 5117(c),
PHMSA is publishing the following list of special permit applications
that have been in process for 180 days or more. The reason(s) for delay
and the expected completion date for action on each application is
provided in association with each identified application.

FOR FURTHER INFORMATION CONTACT: Ryan Paquet, Director, Office of
Hazardous Materials Special Permits and Approvals, Pipeline and
Hazardous Materials Safety Administration, U.S. Department of
Transportation, East Building, PHH-30, 1200 New Jersey Avenue SE.,
Washington, DC 20590-0001,<PHONE_NUMBER>.

Key to ``Reason for Delay''

1. Awaiting additional information from applicant
2. Extensive public comment under review
3. Application is technically complex and is of significant impact or
precedent-setting and requires extensive analysis
4. Staff review delayed by other priority issues or volume of special
permit applications

Meaning of Application Number Suffixes

N--New application
M--Modification request
R--Renewal Request
P--Party To Exemption Request

    Issued in Washington, DC, on June 11, 2013.
Donald Burger,
Chief, General Approvals and Permits.

------------------------------------------------------------------------
                                            Reason for    Estimated date
    Application No.         Applicant          delay       of completion
------------------------------------------------------------------------
                     New Special Permit Applications
------------------------------------------------------------------------
15720-N...............  Digital Wave                 3,1      07-31-2013
                         Corporation
                         Centennial, CO.
15755-N...............  Micronesian                    4      06-30-2013
                         Aviation
                         Corporation dba
                         Americopters
                         Saipan, MP.
15727-N...............  Blackhawk                      4      07-31-2013
                         Helicopters El
                         Cajon, CA.
15767-N...............  Union Pacific                  1      07-31-2013
                         Railroad
                         Company Omaha,
                         NE.
15747-N...............  UPS, Inc.                    2,3      06-30-2013
                         Atlanta, GA.
------------------------------------------------------------------------
                  Renewal Special Permits Applications
------------------------------------------------------------------------
15251-R...............  Suburban Air                   3      06-30-2013
                         Freight, Inc.
                         Omaha, NE.
------------------------------------------------------------------------

[FR Doc. 2013-14345 Filed 6-18-13; 8:45 am]
BILLING CODE 4910-60-M